|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$50,425.74 |
2.68% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$49,833.96 |
2.65% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$48,444.76 |
2.58% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$46,935.24 |
2.50% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$44,920.24 |
2.39% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$44,732.90 |
2.38% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$44,334.36 |
2.36% |
| Waters Corporation |
WAT |
941848103 |
123 |
$44,346.42 |
2.36% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$43,892.28 |
2.33% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$43,273.93 |
2.30% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$42,452.84 |
2.26% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$41,843.90 |
2.23% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$41,447.21 |
2.20% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$40,951.00 |
2.18% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$40,751.04 |
2.17% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$40,882.95 |
2.17% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$40,316.10 |
2.14% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$39,910.72 |
2.12% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$39,263.45 |
2.09% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$38,983.68 |
2.07% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$37,896.74 |
2.02% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$37,842.88 |
2.01% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$37,697.26 |
2.01% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$37,539.45 |
2.00% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$37,337.77 |
1.99% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$37,222.93 |
1.98% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$37,234.30 |
1.98% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$37,177.20 |
1.98% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$37,015.80 |
1.97% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$36,675.32 |
1.95% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$36,387.12 |
1.94% |
| Steris Plc |
STE |
G8473T100 |
177 |
$36,552.27 |
1.94% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$36,285.09 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$36,027.28 |
1.92% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$35,523.04 |
1.89% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$35,586.67 |
1.89% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$34,521.84 |
1.84% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$34,547.10 |
1.84% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$34,017.74 |
1.81% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$33,721.20 |
1.79% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$33,369.15 |
1.78% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$33,357.68 |
1.77% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$32,721.22 |
1.74% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$32,032.77 |
1.70% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$29,888.04 |
1.59% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$29,908.66 |
1.59% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$29,538.00 |
1.57% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$29,406.96 |
1.56% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$24,388.82 |
1.30% |
| US Dollar |
$USD |
|
9,852 |
$9,852.08 |
0.52% |
| Japanese Yen |
$JPY |
|
91,571 |
$570.61 |
0.03% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|